Exclusion criteria were aged < 18 years, diffuse alveolar hemorrhage, chronic lung diseases other than COPD or asthma, directive to withhold intubation, immunosuppression (other than immunosuppression secondary to corticosteroid therapy), and treatment with granulocyte colony-stimulating factor.